The Discounted Cash Flow (DCF) valuation of Biogen Inc (BIIB) is 200.59 USD. With the latest stock price at 149.33 USD, the upside of Biogen Inc based on DCF is 34.3%.
Based on the latest price of 149.33 USD and our DCF valuation, Biogen Inc (BIIB) is a buy. buying Biogen stocks now will result in a potential gain of 34.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.8% | 7.7% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 161.80 - 262.35 | 200.59 |
| Upside | 8.3% - 75.7% | 34.3% |